05.10.2017 14:45:00

Tethyan Resources Mails Meeting Materials to Shareholders

JERSEY, UK, Oct. 5, 2017 /CNW/ - Tethyan Resources PLC(AIM:TETH) (TSX-V:TETH) ("Tethyan" or the "Company") announces that further to its news releases dated September 8, 2017 and September 22, 2017, the Company has mailed a notice of meeting and information circular, along with proxy materials, to its shareholders.  The meeting materials are also available on the Company's SEDAR profile at www.sedar.com and on the Company's website at www.tethyan-resources.com.

The general and special meeting will be held on November 1, 2017 at 12:00 p.m. (London time). Shareholders of record as of September 27, 2017 will be eligible to vote at the meeting.

About Tethyan

Tethyan Resources Plc is a gold and base metal mineral exploration company incorporated in England & Wales (company registration number 3781581). Tethyan Resources listed on AIM (TETH.L) in 2004 and commenced trading on the TSX Venture Exchange on September 6, 2017, under the symbol "TETH".

Tethyan Resources is focused on the Tethyan Metallogenic Belt in Eastern Europe, mainly Serbia, where it is acquiring and exploring a portfolio of quality precious and base metals projects with known mineralisation and compelling drill targets.

Tethyan emphasises responsible engagement with local communities and stakeholders, and is committed to proactively implementing Good International Industry Practice (GIIP) and sustainable health, safety and environmental management.

More information can be found on our website: www.tethyan-resources.com.

TSX Venture Exchange Disclaimer

Neither the TSX Venture Exchange nor its Regulation Services Provider (as such term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. 

Forward Looking Statements

Certain information contained herein constitutes "forward-looking information" under Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to holding the general and special meeting and eligibility of shareholders to vote at the meeting.  Generally, forward-looking information can be identified by the use of forward-looking terminology and phrases or statements that certain actions, events or results "will" occur. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information, including: the receipt of all necessary regulatory approvals, capital expenditures and other costs, and financing and additional capital requirements. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward looking information. The Company will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.

SOURCE Tethyan Resources PLC

Nachrichten zu Sorrento Therapeutics Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Sorrento Therapeutics Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

ConocoPhillips 102,22 -0,35% ConocoPhillips
Sorrento Therapeutics Inc 0,00 38,89% Sorrento Therapeutics Inc
United Therapeutics Corp. 361,10 0,03% United Therapeutics Corp.